One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome. However, what about patients who developed nephrotic ...
Nov 5, 2025
0
11
Instead of wasting hours squatting weights in the gym or pounding miles of pavement in your running shoes, you could instead get all the benefits of a workout just by moving a little bit more like other animals.
Oct 16, 2025
0
18
People with Sweet's syndrome often wake up with a fever, body aches, and blisters on their neck, limbs and face. Also known as acute febrile neutrophilic dermatosis, it is an inflammatory skin disease marked by severe symptoms ...
Oct 6, 2025
0
7
Most folks probably think of gene mutations as something people are born with, but genes can also change later in life, sometimes making people sick.
Aug 18, 2025
0
18
Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer patients treated with immunotherapy, are the main reason certain immunotherapies may fail in treating the ...
Jul 7, 2025
0
42
Organ transplant recipients with advanced cancer, an often overlooked group in cancer care, may benefit from immunotherapy drugs, according to a new study.
Jun 24, 2025
0
25
Certain medications used in the treatment of bone conditions, particularly when combined with corticosteroids, may significantly increase the risk of a rare but serious jaw disease. This finding comes from a study by the ...
Jun 3, 2025
0
50
To help neurologists, clinicians and families understand the current evidence for a new gene therapy for Duchenne muscular dystrophy called delandistrogene moxeparvovec, the American Academy of Neurology (AAN) has issued ...
May 14, 2025
0
17
The Food and Drug Administration's approval in 2023 of lecanemab—a novel Alzheimer's therapy shown in clinical trials to modestly slow disease progression—was met with enthusiasm by many in the field as it represented the ...
May 12, 2025
0
60
The incidence of mild intraocular inflammation (IOI) in the real world occurs more frequently after intravitreal injection of aflibercept than in clinical trials, according to a study published online May 1 in JAMA Ophthalmology.
May 9, 2025
0
18
